173 related articles for article (PubMed ID: 35465681)
21. Optimal management of patients with operable pancreatic head cancer: A Markov decision analysis.
Rieser CJ; Narayanan S; Bahary N; Bartlett DL; Lee KK; Paniccia A; Smith K; Zureikat AH
J Surg Oncol; 2021 Oct; 124(5):801-809. PubMed ID: 34231222
[TBL] [Abstract][Full Text] [Related]
22. Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: A prospective cohort study.
Park Y; Han YB; Kim J; Kang M; Lee B; Ahn ES; Han S; Kim H; Na HY; Han HS; Yoon YS
Pancreatology; 2024 Jun; 24(4):562-571. PubMed ID: 38556428
[TBL] [Abstract][Full Text] [Related]
23. Pancreaticoduodenectomy is justified in a subset of elderly patients with pancreatic ductal adenocarcinoma: A population-based retrospective cohort study of 4,283 patients.
Lu L; Zhang X; Tang G; Shang Y; Liu P; Wei Y; Gong P; Ma L
Int J Surg; 2018 May; 53():262-268. PubMed ID: 29604352
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant therapy for pancreatic cancer changes the composition of the pancreatic parenchyma.
Rykina-Tameeva N; Nahm CB; Mehta S; Gill AJ; Samra JS; Mittal A
HPB (Oxford); 2020 Nov; 22(11):1631-1636. PubMed ID: 32247587
[TBL] [Abstract][Full Text] [Related]
25. Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal Adenocarcinoma.
Macfie R; Berger Y; Liu H; Li T; Imtiaz S; Ang C; Sarpel U; Hiotis S; Labow D; Golas B; Cohen NA
Ann Surg Oncol; 2023 Aug; 30(8):5027-5034. PubMed ID: 37210446
[TBL] [Abstract][Full Text] [Related]
26. Utilization of chemoradiation therapy provides strongest protective effect for avoidance of postoperative pancreatic fistula following pancreaticoduodenectomy: A NSQIP analysis.
Mangieri CW; Strode MA; Moaven O; Clark CJ; Shen P
J Surg Oncol; 2020 Dec; 122(8):1604-1611. PubMed ID: 32935353
[TBL] [Abstract][Full Text] [Related]
27. Mortality and Survival Among Octogenarians with Localized Pancreatic Head Cancer: a National Cancer Database Analysis.
Hue JJ; Bingmer K; Sugumar K; Ocuin LM; Rothermel LD; Winter JM; Ammori JB; Hardacre JM
J Gastrointest Surg; 2021 Oct; 25(10):2582-2592. PubMed ID: 33634421
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant Radiation Is Associated with Fistula Formation Following Pancreaticoduodenectomy.
Zettervall SL; Ju T; Holzmacher JL; Rivas L; Lin PP; Vaziri K
J Gastrointest Surg; 2018 Jun; 22(6):1026-1033. PubMed ID: 29500685
[TBL] [Abstract][Full Text] [Related]
29. Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy.
Yang HK; Park MS; Han K; Eom G; Chung YE; Choi JY; Bang S; Kang CM; Seong J; Kim MJ
Cancer Res Treat; 2024 Jan; 56(1):247-258. PubMed ID: 37605535
[TBL] [Abstract][Full Text] [Related]
30. Critical issues in pathologic evaluation of pancreatic ductal adenocarcinoma resected after neoadjuvant treatment: a narrative review.
Taherian M; Wang H
Chin Clin Oncol; 2022 Jun; 11(3):21. PubMed ID: 35726190
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant Chemotherapy is Associated with Increased Risk of Postoperative DVT After Distal Pancreatectomy for Pancreatic Adenocarcinoma: a NSQIP Analysis.
Robbins KJ; Newcomer KF; Barnell EK; Anzelmo MA; Liu J; Hawkins WG
Ann Surg Oncol; 2024 May; 31(5):2873-2881. PubMed ID: 38151621
[TBL] [Abstract][Full Text] [Related]
32. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
[TBL] [Abstract][Full Text] [Related]
33. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of pancreatic fistula and postoperative complications after pancreaticoduodenectomy in patients with pancreatic ductal adenocarcinoma.
Neeman U; Lahat G; Goykhman Y; Geva R; Peles-Avraham S; Nachmany I; Nakache R; Klausner JM; Lubezky N
Surgeon; 2020 Feb; 18(1):24-30. PubMed ID: 31466841
[TBL] [Abstract][Full Text] [Related]
35. Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Khachfe HH; Hammad AY; AlMasri S; Nassour I; ElAsmar R; Liu H; de Silva A; Kraftician J; Lee KK; Zureikat AH; Paniccia A
J Surg Oncol; 2024 May; 129(6):1097-1105. PubMed ID: 38316936
[TBL] [Abstract][Full Text] [Related]
36. Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes.
Harrison JM; Wo JY; Ferrone CR; Horick NK; Keane FK; Qadan M; Lillemoe KD; Hong TS; Clark JW; Blaszkowsky LS; Allen JN; Castillo CF
Ann Surg Oncol; 2020 May; 27(5):1400-1406. PubMed ID: 31758284
[TBL] [Abstract][Full Text] [Related]
37. Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing.
Lee AJ; Simoneau E; Chiang YJ; Lee JE; Kim MP; Aloia TA; Vauthey JN; Katz MH; Tzeng CD
HPB (Oxford); 2019 Sep; 21(9):1203-1210. PubMed ID: 30799277
[TBL] [Abstract][Full Text] [Related]
38. Weight loss during neoadjuvant chemotherapy impacts perioperative outcomes in patients undergoing surgery for pancreatic cancer.
Doshi S; Abad J; Wells A; Chawla A
Pancreatology; 2023 Dec; 23(8):1020-1027. PubMed ID: 37926598
[TBL] [Abstract][Full Text] [Related]
39. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.
Ferrone CR; Marchegiani G; Hong TS; Ryan DP; Deshpande V; McDonnell EI; Sabbatino F; Santos DD; Allen JN; Blaszkowsky LS; Clark JW; Faris JE; Goyal L; Kwak EL; Murphy JE; Ting DT; Wo JY; Zhu AX; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
Ann Surg; 2015 Jan; 261(1):12-7. PubMed ID: 25599322
[TBL] [Abstract][Full Text] [Related]
40. Impact of Neoadjuvant Therapy on Survival Following Margin-Positive Resection for Pancreatic Cancer.
Chopra A; Zenati M; Hogg ME; Zeh HJ; Bartlett DL; Bahary N; Zureikat AH; Beane JD
Ann Surg Oncol; 2021 Nov; 28(12):7759-7769. PubMed ID: 34027585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]